Charcoal, Activated

Charcoal, Activated

SCHEMBL6627367

NC(=O)CCC(=O)O.[C]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL36056 0.97
Succinamide SCHEMBL27602218 0.97 LMNA (0.64)
Succinamide SCHEMBL27602217 0.97 LMNA (0.64)
Succinic Acid SCHEMBL30870384 0.97 LMNA (0.64)
Succinamide SCHEMBL1864469 0.97 LMNA (0.64)
Hydrochloric Acid SCHEMBL3361793 0.93
Ammonia Solution, Strong SCHEMBL30458050 0.93
SCHEMBL27774324 0.93
Hydrogen Sulfide SCHEMBL419096 0.93
SCHEMBL28225625 0.93 LMNA (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0960108-B1 MATRIX METALLOPROTEINASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2004-10-27 EP claimed
US-6194451-B1 PREVENT RELEASE TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2001-02-27 US claimed
EP-0960108-A1 MATRIX METALLOPROTEINASE INHIBITORS PHARMACIA &amp; UPJOHN S.p.A. (IT) 1999-12-01 EP claimed
WO-1998033788-A1 MATRIX METALLOPROTEINASE INHIBITORS PHARMACIA & UPJOHN S.P.A. (IT) 1998-08-06 WO claimed